Investment
Features
FeesSafety
Academy
More
Pluang+
icon
Up to 4x
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

QUALCOMM, Inc. (QCOM) Stock Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Air Canada to launch non-stop Montréal-Seville flights in Sept 2027, expanding its European network.

Air Canada announced it will start non-stop seasonal flights between Montréal and Seville, Spain, beginning September 8, 2027. This new route is the only direct connection between North America and Seville, enhancing travel options for Canadians and ...

Market News
18 minutes ago
Na
Bullish
news icon
Air Canada to launch non-stop Montréal-Seville flights in Sept 2027, expanding its European network.

Air Canada launches nonstop Montreal-Seville flights starting September 2027, expanding its European network.

Air Canada will begin a new seasonal nonstop flight service between Montreal and Seville, Spain, starting September 8, 2027. This route is the only nonstop connection between North America and Seville, enhancing travel options for leisure and busines...

Market News
18 minutes ago
Na
Bullish
news icon
Air Canada launches nonstop Montreal-Seville flights starting September 2027, expanding its European network.

TSOs prioritize software investments to boost grid security and capacity amid rising demand

Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...

Market News
18 minutes ago
Abi Research
Neutral
TSOs prioritize software investments to boost grid security and capacity amid rising demand

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
2 hours ago
Na
Bullish
news icon
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
2 hours ago
Na
Bullish
news icon
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.

The global anthracite market, valued at $11.9 billion in 2025, is projected to grow to $16.8 billion by 2035 with a 3.5% CAGR. Growth is fueled by rising demand in steel production, water filtration, and advanced industrial uses due to anthracite's h...

Market News
3 hours ago
Researchandmarkets.Com
Bullish
news icon
Global anthracite market to reach $16.8B by 2035, driven by steel and water filtration demand.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
3 hours ago
Not Specified
Bullish
news icon
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Intel stock nearly triples in 2026, but a 2016 $10K investment still lags behind the S&P 500.

Intel's stock price has surged nearly threefold in 2026, reflecting strong market performance this year. However, an investment of $10,000 made in Intel shares back in 2016 would still have underperformed compared to simply investing in the S&P 500 i...

Market News
4 hours ago
Chris Neiger
Bullish
news icon
Intel stock nearly triples in 2026, but a 2016 $10K investment still lags behind the S&P 500.

IonQ seen as speculative buy with growth potential from new tech and partnerships despite risks.

IonQ is considered a speculative buy with a long-term price target of $50–$60, driven by its Superion 256 chip and collaborations with SkyWater and Nvidia that could enhance scalability and reduce costs. While revenue growth is strong, much of it com...

Analyst Insights
4 hours ago
Seeking Alpha
Bullish
news icon
IonQ seen as speculative buy with growth potential from new tech and partnerships despite risks.

ASML reports 55% sales growth and raises margin forecast amid strong demand through 2028

ASML Holding N.V. posted a strong quarter with 55% year-over-year sales growth and improved profit margins driven by high-margin upgrades and capacity limits. Customer demand is expected to exceed ASML's supply until at least 2028, supported by €5.7 ...

Company Fundamentals
4 hours ago
Seeking Alpha
Bullish
news icon
ASML reports 55% sales growth and raises margin forecast amid strong demand through 2028
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

Key Stats

  • Market Cap
    $188.86B
  • Volume
    12,280,716
  • Sector
    Technology
  • 52W High
    $251.10
  • 52W Low
    $124.07
  • Typical Hold Time
    87 Days
  • Enterprise Value
    $195.82B
  • Div Yield
    2.08%
  • Trading Activity
    71% Sell | 29% Buy
$173.98
52W Low: $124.07
07 Apr 2026
52W High: $251.1
29 May 2026

Track QUALCOMM, Inc. (QCOM) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, QUALCOMM, Inc. has traded between a low of $124.07 and a high of $251.1, highlighting its annual price range. Buy and sell QUALCOMM, Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!